Sort   by:  
 Page size 
Heart failure is a disease with increasing prevalence, while present treatment options, especially for heart failure with preserved ejection fraction (HFpEF), are inadequate. Hypertension and obesity-related metabolic dysfunctions are important risk factors for HFpEF development and progression. Nit...
ORGANISM(S): Mus musculus (Mouse) 
2025-03-18 | PXD058165 | Pride
Nitro-fatty acids (NO2-FAs) act as potent electrophiles due to the presence of a nitro group attached to the double bond in their carbon chain. This chemical configuration enables them to react with nucleophilic residues in proteins, specifically cysteines, histidines and lysines, via a process know...
ORGANISM(S): Arabidopsis thaliana (Mouse-ear cress) 
2026-09-29 | PXD060471 | Pride
Lack of non-invasive diagnostic tools and effective therapies constitute two of the major hurdles for a bona fide treatment against non-alcoholic steatohepatitis (NASH) progression and/or regression of nonalcoholic fatty liver disease (NAFLD). Nitro-oleic acid (OA-NO2) has been proven effective in m...
ORGANISM(S): Mus musculus 
2019-02-08 | GSE126204 | GEO
Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice
Nitro-fatty acids (NFAs) are endogenous lipid mediators causing a broad spectrum of anti-inflammatory effects by covalent modification of key proteins within inflammatory signaling pathways. Their potential as anti-tumorigenic therapeutics has recently been demonstrated in animal models of solid tum...
ORGANISM(S): Homo sapiens (Human) 
2024-03-26 | PXD041458 | Pride
Sort   by:  
 Page size